Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism METTL3 inhibitors(methyltransferase 3, N6-adenosine-methyltransferase complex catalytic subunit inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Autoimmune Diseases | Discovery | - | 15 Jun 2023 | |
Neoplasms | Discovery | - | 15 Jun 2023 | |
Neuritis | Discovery | - | 15 Jun 2023 | |
Other Diseases | Discovery | - | 15 Jun 2023 |